Arch Biopartners Market Cap 2021-2024 | ACHFF

Arch Biopartners market cap as of November 18, 2024 is $0.09B.

Arch Biopartners market cap history and chart from 2021 to 2024. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding.

Arch Biopartners Market Cap 2021-2024 | ACHFF

Arch Biopartners market cap history and chart from 2021 to 2024. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding.
Related Stocks
Company NameMarket
Cap
Zoetis (ZTS)$79B
Takeda Pharmaceutical (TAK)$43.3B
Sandoz Group AG (SDZNY)$19.5B
Merck (MKKGY)$19.5B
Astellas Pharma (ALPMY)$19.4B
United Therapeutics (UTHR)$16.2B
Summit Therapeutics (SMMT)$13.5B
Shionogi (SGIOY)$12.1B
Neurocrine Biosciences (NBIX)$11.9B
Catalent (CTLT)$10.7B
Jazz Pharmaceuticals (JAZZ)$7.4B
Orion OYJ (ORINY)$6.7B
Madrigal Pharmaceuticals (MDGL)$6.3B
Corcept Therapeutics (CORT)$5.4B
Ionis Pharmaceuticals (IONS)$5.4B
Crinetics Pharmaceuticals (CRNX)$5.1B
PTC Therapeutics (PTCT)$3B
Dyne Therapeutics (DYN)$2.9B
AMNEAL PHARMACEUTICALS, INC (AMRX)$2.6B
Catalyst Pharmaceuticals (CPRX)$2.5B
Arrowhead Pharmaceuticals (ARWR)$2.3B
NewAmsterdam Pharma (NAMS)$2.3B
Soleno Therapeutics (SLNO)$2.2B
Evotec AG (EVO)$1.9B
Centessa Pharmaceuticals (CNTA)$1.8B
Recursion Pharmaceuticals (RXRX)$1.8B
Xencor (XNCR)$1.6B
BioCryst Pharmaceuticals (BCRX)$1.5B
Ocular Therapeutix (OCUL)$1.4B
Harrow (HROW)$1.4B